These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 29523019
21. Candidate Urine Peptide Biomarkers for IgA Nephropathy: Where Are We Now? Marek-Bukowiec K, Konieczny A, Ratajczyk K, Witkiewicz W. Dis Markers; 2018; 2018():5205831. PubMed ID: 29606986 [Abstract] [Full Text] [Related]
22. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1. Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J. BMC Nephrol; 2016 Apr 05; 17():40. PubMed ID: 27044423 [Abstract] [Full Text] [Related]
23. Regulation of IgA Class Switch Recombination in Immunoglobulin A Nephropathy: Retinoic Acid Signaling and BATF. He L, Peng X, Chen Y, Liu G, Liu Z, Zhu J, Liu Y, Liu H, Liang Y, Liu F, Sun L, Peng Y. Am J Nephrol; 2016 Apr 05; 43(3):179-94. PubMed ID: 27073891 [Abstract] [Full Text] [Related]
24. Transcriptomic and Proteomic Profiling Provides Insight into Mesangial Cell Function in IgA Nephropathy. Liu P, Lassén E, Nair V, Berthier CC, Suguro M, Sihlbom C, Kretzler M, Betsholtz C, Haraldsson B, Ju W, Ebefors K, Nyström J. J Am Soc Nephrol; 2017 Oct 05; 28(10):2961-2972. PubMed ID: 28646076 [Abstract] [Full Text] [Related]
25. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients. Liang Y, Zhao G, Tang L, Zhang J, Li T, Liu Z. Exp Cell Res; 2016 Oct 01; 347(2):312-21. PubMed ID: 27542871 [Abstract] [Full Text] [Related]
26. Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis. Gan T, Qu LX, Qu S, Qi YY, Zhang YM, Wang YN, Li Y, Liu LJ, Shi SF, Lv JC, Zhang H, Peng YJ, Zhou XJ. Int Immunopharmacol; 2024 May 10; 132():111905. PubMed ID: 38552291 [Abstract] [Full Text] [Related]
27. Establishment of a 2-D human urinary proteomic map in IgA nephropathy. Park MR, Wang EH, Jin DC, Cha JH, Lee KH, Yang CW, Kang CS, Choi YJ. Proteomics; 2006 Feb 10; 6(3):1066-76. PubMed ID: 16372274 [Abstract] [Full Text] [Related]
28. 1 H NMR-based metabolomics study for identifying urinary biomarkers and perturbed metabolic pathways associated with severity of IgA nephropathy: a pilot study. Kalantari S, Nafar M, Samavat S, Parvin M. Magn Reson Chem; 2017 Aug 10; 55(8):693-699. PubMed ID: 28042675 [Abstract] [Full Text] [Related]
29. Diagnostic urinary proteome profile for immunoglobulin a nephropathy. Samavat S, Kalantari S, Nafar M, Rutishauser D, Rezaei-Tavirani M, Parvin M, Zubarev RA. Iran J Kidney Dis; 2015 May 10; 9(3):239-48. PubMed ID: 25957429 [Abstract] [Full Text] [Related]
30. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography. Kalantari S, Rutishauser D, Samavat S, Nafar M, Mahmudieh L, Rezaei-Tavirani M, Zubarev RA. PLoS One; 2013 May 10; 8(12):e80830. PubMed ID: 24339887 [Abstract] [Full Text] [Related]
31. A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy. Gao J, Wang Y, Dong Z, Yan Z, Jia X, Tian Y. BMC Med Inform Decis Mak; 2012 Jun 27; 12():58. PubMed ID: 22738421 [Abstract] [Full Text] [Related]
32. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy. Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM. BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996 [Abstract] [Full Text] [Related]
33. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Ding H, He Y, Li K, Yang J, Li X, Lu R, Gao W. Clin Immunol; 2007 May 15; 123(2):227-34. PubMed ID: 17360238 [Abstract] [Full Text] [Related]
34. Identification of potential biomarkers and therapeutic targets for human IgA nephropathy and hypertensive nephropathy by bioinformatics analysis. Cui Y, Liu S, Cui W, Gao D, Zhou W, Luo P. Mol Med Rep; 2017 Sep 15; 16(3):3087-3094. PubMed ID: 28713898 [Abstract] [Full Text] [Related]
35. [Feasibility of peptide mass fingerprinting for differential diagnosis of IgA and non-IgA nephropathy]. Gao J, Wang Y, Wen XY, Lu HH, Dong ZN, Tian YP. Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug 15; 31(8):1309-13. PubMed ID: 21868311 [Abstract] [Full Text] [Related]
36. Expressions of mRNA for innate immunity-associated functional molecules in urinary sediment in immunoglobulin A nephropathy. Tsuruga K, Aizawa T, Watanabe S, Tsugawa K, Yoshida H, Imaizumi T, Ito E, Tanaka H. Nephrology (Carlton); 2015 Dec 15; 20(12):916-21. PubMed ID: 26058859 [Abstract] [Full Text] [Related]
37. Markers for the progression of IgA nephropathy. Maixnerova D, Reily C, Bian Q, Neprasova M, Novak J, Tesar V. J Nephrol; 2016 Aug 15; 29(4):535-41. PubMed ID: 27142988 [Abstract] [Full Text] [Related]
38. Evidence for genetic factors in the development and progression of IgA nephropathy. Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF. Kidney Int; 2000 May 15; 57(5):1818-35. PubMed ID: 10792601 [Abstract] [Full Text] [Related]
39. Comprehensive metabolomic profiling in early IgA nephropathy patients reveals urine glycine as a prognostic biomarker. Park S, Lee J, Yang SH, Lee H, Kim JY, Park M, Kim KH, Moon JJ, Cho S, Lee S, Kim Y, Lee H, Lee JP, Jeong CW, Kwak C, Joo KW, Lim CS, Kim YS, Hwang GS, Kim DK. J Cell Mol Med; 2021 Jun 15; 25(11):5177-5190. PubMed ID: 33939273 [Abstract] [Full Text] [Related]
40. Post-transplant immunoglobulin A deposition and nephropathy in allografts. Sofue T, Suzuki H, Ueda N, Kushida Y, Minamino T. Nephrology (Carlton); 2018 Jul 15; 23 Suppl 2():4-9. PubMed ID: 29968406 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]